Article metrics

Download PDFPDF

Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection

 

Online download statistics by month:

Online download statistics by month: December 2019 to October 2024

AbstractFullPdf
Dec 2019110
Jan 2020550
Feb 202022229
Mar 2020313117
Apr 202028289
May 202029292
Jun 2020262613
Jul 202032321
Aug 202022221
Sep 2020323211
Oct 202035356
Nov 2020282810
Dec 202015157
Jan 202132328
Feb 2021494917
Mar 2021454517
Apr 2021464722
May 2021404014
Jun 202140406
Jul 2021474714
Aug 2021434310
Sep 2021424224
Oct 2021282812
Nov 2021232310
Dec 202143438
Jan 202244467
Feb 202234357
Mar 202232326
Apr 202227297
May 2022767911
Jun 202272734
Jul 2022545418
Aug 202264664
Sep 202243433
Oct 2022545711
Nov 2022424421
Dec 2022474713
Jan 2023575712
Feb 202378788
Mar 2023575812
Apr 202331319
May 2023485014
Jun 2023707028
Jul 2023313214
Aug 202319199
Sep 202315161
Oct 2023384212
Nov 2023808213
Dec 202319819816
Jan 2024737524
Feb 202414915013
Mar 2024555617
Apr 2024515228
May 2024393914
Jun 202438377
Jul 2024484922
Aug 2024484714
Sep 2024323212
Oct 20244548137
Total26732708796